EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice

Shuang Chen, Chensong Huang, Kang Li, Maosheng Cheng, Caihua Zhang, Jianqi Xiong, Guoli Tian, Ruoxing Zhou, Rongsong Ling, Xiaochen Wang, Gan Xiong, Zhihui Zhang und 7 weitere

Journal of Clinical Investigation · 03.03.2025 · 135 (5)

DOI: 10.1172/jci180893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 07.01.2025. Verfasst von Shuang Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Department of Medical Oncology, Department of Pancreato-Biliary Surgery, Department of Radiation Oncology, Cancer …. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Neoplastic Stem Cells, Tumor Escape. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-initiating cells (TICs) play a key role in cancer progression and immune escape. However, how TICs evade immune elimination remains poorly characterized. Combining single-cell RNA-Seq (scRNA-Seq), dual-recombinase–based lineage tracing, and other approaches, we identified a WNT-activated subpopulation of malignant cells that act as TICs in vivo. We found intensive reciprocal interactions between TICs and immune-regulatory tumor-associated macrophages (Reg-TAMs) via growth arrest–specific 6/AXL receptor tyrosine kinase/MER proto-oncogene, tyrosine kinase (GAS6/AXL/MERTK) signaling pathways, which facilitated the immune escape of TICs. In this study, we used chemical inhibitors and Axl / Mertk conditional double-KO (cDKO) mice to demonstrate that inhibiting the interaction between TIC-derived GAS6 and AXL/MERTK in Reg-TAMs reactivated antitumor immune responses. We identified CCL8 as a critical mediator of the GAS6/AXL/MERTK pathway, primarily by inhibiting Treg infiltration into the tumor. Furthermore, the AXL/MERTK signaling blockade sensitized tumor cells to anti–programmed cell death 1 (anti–PD-1) treatment. Thus, we elucidated a detailed mechanism by which TICs evade tumor immunity, providing insights into strategies to eradicate TICs that escape conventional immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesNeoplastic Stem CellsTumor EscapeAnimalsMiceAxl Receptor Tyrosine KinaseReceptor Protein-Tyrosine KinasesProto-Oncogene ProteinsMice, Knockoutc-Mer Tyrosine KinaseProto-Oncogene MasSignal TransductionIntercellular Signaling Peptides and ProteinsCell Line, TumorHumansGrowth Arrest-Specific Protein 6

Stichwörter der Autor:innen

Cancer immunotherapyOncology

Substanzen

Axl Receptor Tyrosine KinaseReceptor Protein-Tyrosine KinasesProto-Oncogene Proteinsc-Mer Tyrosine KinaseProto-Oncogene MasIntercellular Signaling Peptides and ProteinsGrowth Arrest-Specific Protein 6Mertk protein, mouseAXL receptor tyrosine kinase, mouse

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Department of Medical Oncology, Department of Pancreato-Biliary Surgery, Department of Radiation Oncology, Cancer Center, Center for Translational Medicine, The First Affiliated Hospit…
  • Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
  • Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shangha…
  • Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Guangdong Province
  • The Open Funding of the State Key Laboratory of Oral Diseases
  • Guangdong Basic and Applied Basic Research Foundation
  • Guangzhou Science and Technology Plan Project

Zitieren

APA

Chen, S., Huang, C., Li, K., Cheng, M., Zhang, C., Xiong, J., Tian, G., Zhou, R., Ling, R., Wang, X., Xiong, G., Zhang, Z., Ma, J., Zhu, Y., Zhou, B., Peng, L., Peng, Z., Li, H., & Chen, D. (2025). Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice. Journal of Clinical Investigation, 135(5). https://doi.org/10.1172/jci180893

Vancouver

Chen S, Huang C, Li K, Cheng M, Zhang C, Xiong J, et al. Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice. Journal of Clinical Investigation. 2025;135(5). doi:10.1172/jci180893

BibTeX
@article{Chen2025,
  author = {Chen, Shuang and Huang, Chensong and Li, Kang and Cheng, Maosheng and Zhang, Caihua and Xiong, Jianqi and Tian, Guoli and Zhou, Ruoxing and Ling, Rongsong and Wang, Xiaochen and Xiong, Gan and Zhang, Zhihui and Ma, Jieyi and Zhu, Yan and Zhou, Bin and Peng, Liang and Peng, Zhenwei and Li, Heping and Chen, Demeng},
  title = {Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {5},
  doi = {10.1172/jci180893}
}
Kostenlos starten →